Page last updated: 2024-11-02

pd 98059 and Chemical and Drug Induced Liver Injury

pd 98059 has been researched along with Chemical and Drug Induced Liver Injury in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marra, F1
Arrighi, MC1
Fazi, M1
Caligiuri, A1
Pinzani, M1
Romanelli, RG1
Efsen, E1
Laffi, G1
Gentilini, P1

Other Studies

1 other study available for pd 98059 and Chemical and Drug Induced Liver Injury

ArticleYear
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat.
    Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:4

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Carbon Tetrachloride; Cell Division; Cell Mov

1999